These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26210447)

  • 1. Quantification of Ataxin-3 and Ataxin-7 aggregates formed in vivo in Drosophila reveals a threshold of aggregated polyglutamine proteins associated with cellular toxicity.
    Vinatier G; Corsi JM; Mignotte B; Gaumer S
    Biochem Biophys Res Commun; 2015 Sep; 464(4):1060-1065. PubMed ID: 26210447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of Ataxin-3 (atx-3) Aggregation by Structural Mass Spectrometry Techniques: A Rationale for Expedited Aggregation upon Polyglutamine (polyQ) Expansion.
    Scarff CA; Almeida B; Fraga J; Macedo-Ribeiro S; Radford SE; Ashcroft AE
    Mol Cell Proteomics; 2015 May; 14(5):1241-53. PubMed ID: 25700012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity and aggregation of the polyglutamine disease protein, ataxin-3 is regulated by its binding to VCP/p97 in Drosophila melanogaster.
    Ristic G; Sutton JR; Libohova K; Todi SV
    Neurobiol Dis; 2018 Aug; 116():78-92. PubMed ID: 29704548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PolyQ-expanded proteins impair cellular proteostasis of ataxin-3 through sequestering the co-chaperone HSJ1 into aggregates.
    Yue HW; Hong JY; Zhang SX; Jiang LL; Hu HY
    Sci Rep; 2021 Apr; 11(1):7815. PubMed ID: 33837238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense oligonucleotide-mediated exon skipping as a strategy to reduce proteolytic cleavage of ataxin-3.
    Toonen LJ; Schmidt I; Luijsterburg MS; van Attikum H; van Roon-Mom WM
    Sci Rep; 2016 Oct; 6():35200. PubMed ID: 27731380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of the polyglutamine protein ataxin-3 with Rad23 regulates toxicity in Drosophila models of Spinocerebellar Ataxia Type 3.
    Sutton JR; Blount JR; Libohova K; Tsou WL; Joshi GS; Paulson HL; Costa MDC; Scaglione KM; Todi SV
    Hum Mol Genet; 2017 Apr; 26(8):1419-1431. PubMed ID: 28158474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyglutamine tracts regulate beclin 1-dependent autophagy.
    Ashkenazi A; Bento CF; Ricketts T; Vicinanza M; Siddiqi F; Pavel M; Squitieri F; Hardenberg MC; Imarisio S; Menzies FM; Rubinsztein DC
    Nature; 2017 May; 545(7652):108-111. PubMed ID: 28445460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation.
    Johnson SL; Ranxhi B; Libohova K; Tsou WL; Todi SV
    Elife; 2020 Sep; 9():. PubMed ID: 32955441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fine balance between Prpf19 and Exoc7 in achieving degradation of aggregated protein and suppression of cell death in spinocerebellar ataxia type 3.
    Chen ZS; Huang X; Talbot K; Chan HYE
    Cell Death Dis; 2021 Feb; 12(2):136. PubMed ID: 33542212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis.
    Chai Y; Shao J; Miller VM; Williams A; Paulson HL
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9310-5. PubMed ID: 12084819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel polyglutamine model uncouples proteotoxicity from aging.
    Christie NT; Lee AL; Fay HG; Gray AA; Kikis EA
    PLoS One; 2014; 9(5):e96835. PubMed ID: 24817148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trehalose prevents the formation of aggregates of mutant ataxin-3 and reduces soluble ataxin-3 protein levels in an SCA3 cell model.
    Wang Z; Wang M; Huang Y; Ma Z; Gao W; Zhang T; Deng J; Cheng X; Liu Y; Wang B; Qi Y; Yang M; He F
    Neuroscience; 2024 Sep; 555():76-82. PubMed ID: 38964453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant Ataxin-3-Containing Aggregates (MATAGGs) in Spinocerebellar Ataxia Type 3: Dynamics of the Disorder.
    Raj K; Akundi RS
    Mol Neurobiol; 2021 Jul; 58(7):3095-3118. PubMed ID: 33629274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational targeting of fibrillar polyglutamine proteins in live cells escalates aggregation and cytotoxicity.
    Kvam E; Nannenga BL; Wang MS; Jia Z; Sierks MR; Messer A
    PLoS One; 2009 May; 4(5):e5727. PubMed ID: 19492089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70.
    Warrick JM; Chan HY; Gray-Board GL; Chai Y; Paulson HL; Bonini NM
    Nat Genet; 1999 Dec; 23(4):425-8. PubMed ID: 10581028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyglutamine expansion diseases: More than simple repeats.
    Silva A; de Almeida AV; Macedo-Ribeiro S
    J Struct Biol; 2018 Feb; 201(2):139-154. PubMed ID: 28928079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging causes distinct characteristics of polyglutamine amyloids in vivo.
    Tonoki A; Kuranaga E; Ito N; Nekooki-Machida Y; Tanaka M; Miura M
    Genes Cells; 2011 May; 16(5):557-64. PubMed ID: 21466635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila.
    Chan HY; Warrick JM; Gray-Board GL; Paulson HL; Bonini NM
    Hum Mol Genet; 2000 Nov; 9(19):2811-20. PubMed ID: 11092757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyglutamine-Independent Features in Ataxin-3 Aggregation and Pathogenesis of Machado-Joseph Disease.
    Carvalho AL; Silva A; Macedo-Ribeiro S
    Adv Exp Med Biol; 2018; 1049():275-288. PubMed ID: 29427109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential toxicity of ataxin-3 isoforms in Drosophila models of Spinocerebellar Ataxia Type 3.
    Johnson SL; Blount JR; Libohova K; Ranxhi B; Paulson HL; Tsou WL; Todi SV
    Neurobiol Dis; 2019 Dec; 132():104535. PubMed ID: 31310802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.